Skip to content

Allphase Pharma Consulting, LLC

A Professional Service Provider for the Pharma Industry

Allphase Pharma Consulting, LLC
Menu
Secondary Menu

Primary menu

  • CONTACT
  • BLOGS
    • The Viewpoint
    • The News
    • Recent Literature
    • Did you know…?
    • QIDP Antibiotics
  • LEGAL
  • WELCOME

Secondary menu

  • The News
  • The Viewpoint
  • Did you know…?
  • Recent Literature
  • QIDP Antibiotics

Tag Archives: MMWR

CDC Report on Pan-Resistant NDM Klebsiella in Nevada– A Sad Tale

Posted on January 19, 2017 by Harald — No Comments ↓

During the past few weeks the case of a patient with MDR Klebsiella infection has made the news. We are told that this particular pathogen is “resistant to 26 antibiotics”. We were informed that the patient had multiple prior hospitalizations Continue reading CDC Report on Pan-Resistant NDM Klebsiella in Nevada– A Sad Tale→

Share this:

  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email

Like this:

Like Loading...
Posted in Recent Literature, The News, The Viewpoint | Tagged Achaogen, AIDS activism, aminoglycoside, antibiotic blog, approved veterinary drugs, BARDA, CDC, Centers for Disease Control and Prevention, Churchill, colistin resistance, compassionate use, drug availability in USA, eravacycline, FDA, fosfomycin IV, Harald Reinhart, India and lack of hygiene, mcr-1 gene, MDR, miasma, MMWR, multi-drug resistant, NCE, NDM Klebsiella pneumoniae, omadacycline, plazomicin, polymyxin B, Spero Therapeutics, stockpiling antibiotics, sulfonamide, tigecycline, Tygacil, Unasyn, USA approved antibiotics, vancomycin, WHO List of Critically Important Antibiotics, Zavante Therapeutics, Zosyn, ZTI-01 | Leave a reply

Primary Sidebar Widget Area

Posts and Blogs

  • The 10 x ’20 Initiative – A Retrospective
  • BAFF / APRIL Inhibitors Homing in on IgAN
  • THE UTILITY OF FUTILITY
  • Sulopenem uUTI – Does It Suffice?
  • PUBLICATION OVERACHIEVERS
  • BLUJEPA / Gepotidacin APPROVED FOR UNCOMPLICATED UTI – 1
  • Gepotidacin ABSSSI – How to Fail Adaptively
  • A Critical Review of WHO’s List of Antibacterials in Clinical Development
  • Some Thoughts about the New Coronavirus Syndrome and its Transmission
  • Connections: From Mima/Herellea to Acinetobacter to the Double Helix to Lwoff to … CRAB

Subscribe to AllphasePharma Blogs via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Tags

ABSSSI Achaogen Allphase Pharma Consulting aminoglycoside antibiotic blog Avelox Bayer Ceftazidime/avibactam cIAI ciprofloxacin colistin Cubicin Cubist cUTI dalbavancin Dalvance daptomycin delafloxacin eravacycline FDA fosfomycin GSK Harald Reinhart levofloxacin Merck meropenem moxifloxacin MRSA Novartis omadacycline Orbactiv oritavancin P. aeruginosa Pfizer PK/PD plazomicin QIDP solithromycin tedizolid tetracycline Tetraphase tigecycline Tygacil vancomycin VAP

Footer menu

  • CONTACT
  • BLOGS
  • LEGAL
  • WELCOME
  • Email
Copyright © 2025 Allphase Pharma Consulting, LLC. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up
%d